Corrigendum to “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” [Eur J Cancer 47 (12) (2011) 1826–1836]
Stephen J. Clarke, Sonia Yip, Chris Brown, Guy A. van Hazel, David T. Ransom, David Goldstein, G. Mark Jeffrey, Niall C. Tebbutt, Martin Buck, Raymond M. Lowenthal, Amy Boland, Val Gebski, John ZalcbeТом:
48
Рік:
2012
Мова:
english
DOI:
10.1016/j.ejca.2011.12.001
Файл:
PDF, 145 KB
english, 2012